14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 9 May 2024

Trading levels for APRE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.41 4.64 %
R2 5.34 3.31 %
R1 5.30 2.49 %
Current price: 5.17
Support S1 5.16 -0.169 %
S2 5.12 -0.99 %
S3 5.05 -2.32 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.35 22.82 %
R2 6.19 19.73 %
R1 6.16 19.15 %
Current price 5.17
Support S1 5.12 -0.97%
S2 5.10 -1.35%
S3 5.08 -1.66%

APRE Predictions History

2 years ago
jimhanleyiii.267243 predicted that APRE for 2021-10-29 is going

Rank:

3 years ago
JS predicted that APRE for 2021-03-11 is going $5.78 (-2.20%)

3 years ago
anncmarie37.220642 predicted that APRE for 2021-03-11 is going $5.55 (-3.14%)

Rank:

3 years ago
JS predicted that APRE for 2021-01-15 is going $5.31 (3.11%)

3 years ago
Joel Prudencio predicted that APRE for 2021-01-15 is going

Rank:
Click to get the best stock tips daily for free!

About Aprea Therapeutics Inc.

Aprea Therapeutics. Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR... APRE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT